Feasibility Study of Anti-inflammatory Cytokines in Whole Blood in Osteoarthritis Patients

Completed

Conditions studied: Osteoarthritis

In brief

This is a feasibility study to determine if anti-inflammatory cytokines can be concentrated from patients with osteoarthritis.

Key facts

Study ID

NCT01050894

Run by

Zimmer Biomet

People needed

105

Starts

2010-05-01

Expected to finish

2012-01-01

Last updated by the study team

2017-03-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• radiographic evidence of osteoarthritis
• signed informed consent

You may not qualify if…

• Pregnancy
• < 18 years of age
• blood clotting disorder or active hematologic cancer
• undergoing chemotherapy
• history of rheumatoid arthritis
• septic joint or fracture
• active infection or history of chronic infection
• use of cytokine blocking drugs with the last 6 months
• intra-articular steroid or hyaluronic acid (HA) injection within last 6 months

Where it is running

• OrthoIndy — Indianapolis, Indiana, United States
• Orthopaedic Surgery, Kentucky Clinic — Lexington, Kentucky, United States
• Ohio State University Sports Medicine Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.